Q2 2020 Puma Biotechnology Inc Earnings Call

6/8/2020 16:30

Conference Call Puma Biotechnology Inc

Puma Biotechnology Inc Conference call or earnings call will be held on Aug 6, 2020
During the earnings conference call’s session, Puma Biotechnology Inc will provide updated information and financial performance report status.
In order to join the earning call, dial the conference’s bridge and key in the PIN code. Contact Puma Biotechnology Inc for this information
More and more companies choose to conduct their earnings calls through conference calls and online meetings and it’s important to keep up to date with all relevant information.
Need a conference calls service solution? Try QCONF conferencing today, Sign up now and get 5 free conference calls (no credit card required)
Is this is your first earnings call? Check out Nasdaq guide for how to read an earnings report?
Unless otherwise provided in this Annual Report, references to the "Company," "we," "us," and "our" refer to Puma Biotechnology, Inc., a Delaware corporation formed on April 27, 2007 and formerly known as Innovative Acquisitions Corp., together with its wholly-owned subsidiary, Puma Biotechnology Ltd., and all references to "Former Puma" refer to Puma Biotechnology, Inc., a privately-held Delaware corporation formed on September 15, 2010, that merged with and into us in October 2011. We refer to this transaction as the "Merger." We are a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. We in-license the global development and commercialization rights to three drug candidates--PB272 (neratinib (oral)), PB272 (neratinib (intravenous)) and PB357.
Read more Conference Call

Puma Biotechnology Inc (PBYI)

10880 Wilshire Boulevard, Los Angeles California 90024, United States